Next Article in Journal
The Evidence for Sparsentan-Mediated Inhibition of INa and IK(erg): Possibly Unlinked to Its Antagonism of Angiotensin II or Endothelin Type a Receptor
Next Article in Special Issue
Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)
Previous Article in Journal
Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease
Previous Article in Special Issue
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
 
 
Article

Article Versions Notes

Biomedicines 2022, 10(1), 84; https://doi.org/10.3390/biomedicines10010084
Action Date Notes Link
article pdf uploaded. 31 December 2021 15:23 CET Version of Record https://www.mdpi.com/2227-9059/10/1/84/pdf-vor
article supplementary file uploaded. 31 December 2021 15:23 CET - https://www.mdpi.com/2227-9059/10/1/84#supplementary
article xml file uploaded 5 January 2022 05:24 CET Original file -
article xml uploaded. 5 January 2022 05:24 CET Update https://www.mdpi.com/2227-9059/10/1/84/xml
article pdf uploaded. 5 January 2022 05:24 CET Updated version of record https://www.mdpi.com/2227-9059/10/1/84/pdf
article html file updated 5 January 2022 05:26 CET Original file -
article html file updated 31 July 2022 01:34 CEST Update https://www.mdpi.com/2227-9059/10/1/84/html
Back to TopTop